OpGen Reports 2016 Second Quarter Financial Results and Provides Business Update
Aug 09, 2016 20:02 pm UTC| Business
GAITHERSBURG, Md., Aug. 09, 2016 -- OpGen, Inc. (NASDAQ:OPGN) today reported financial and operational results for the three and six months ended June 30, 2016. Highlights of the second quarter and recent weeks...
Immune Design Reports Second Quarter 2016 Financial Results and Provides Corporate Update
Aug 09, 2016 20:02 pm UTC| Business
SEATTLE and SOUTH SAN FRANCISCO, Aug. 09, 2016 -- Immune Design (Nasdaq:IMDZ), a clinical-stage immunotherapy company focused on oncology, today reported financial results and a corporate update for the second quarter...
Aug 09, 2016 20:01 pm UTC| Business
OMAHA, Neb., Aug. 09, 2016 -- Green Plains Inc. (NASDAQ:GPRE) today announced that it intends to offer, subject to market and other conditions, $150 million aggregate principal amount of convertible senior notes due...
Aug 09, 2016 20:01 pm UTC| Business
CHICAGO, Aug. 09, 2016 -- Allscripts(NASDAQ:MDRX) and Hospital IQ, Inc. entered into a strategic partnership to make Hospital IQ’s predictive analytics platform available to Allscripts SunriseTM and Allscripts EPSiTM...
Fossil Group, Inc. Reports Second Quarter Fiscal Year 2016 Results
Aug 09, 2016 20:01 pm UTC| Business
Second Quarter Net Sales of $685 million; Diluted EPS of $0.12 Updates Fiscal 2016 Guidance and Provides Third Quarter Guidance Announces Amendment to Credit Agreement RICHARDSON, Texas, Aug. 09, 2016 -- Fossil...
ZIOPHARM Reports Second-Quarter 2016 Financial Results and Provides Update on Recent Activities
Aug 09, 2016 20:01 pm UTC| Business
BOSTON, Aug. 09, 2016 -- ZIOPHARM Oncology, Inc. (Nasdaq:ZIOP) today announced financial results for the second quarter ended June 30, 2016, and provided an update on the Company’s recent activities. "ZIOPHARM had a...
Editas Medicine Announces Second Quarter 2016 Results and Update
Aug 09, 2016 20:01 pm UTC| Business
Exclusive license to high-fidelity Cas9 and Cas9 PAM variants from Massachusetts General Hospital further advances leading genome editing platform Strategic partnership with Adverum to explore delivery of genomic...